Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sally Barbour

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of the Advanced Practitioner in Oncology|February 18, 2021
2018-2019 Drug Updates in Solid TumorsSally Barbour
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 6, 2015
Safety and tolerability of eribulin mesylate in patients with pretreated metastatic breast cancerSusan Goodin, Sally Barbour, James Song, et al.
Journal of the Advanced Practitioner in Oncology|January 25, 2021
Evaluation of the Role and Impact of Ambulatory Clinical Pharmacists in an Academic Comprehensive Cancer CenterLaura A Meleis, Mallika P Patel, Michael DeCoske, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2007
A phase II trial of carboplatin/vinorelbine with pegfilgrastim support for the treatment of patients with advanced non-small cell lung cancerRichard F Riedel, Carolyn Andrews, Jennifer Garst, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2009
Antiemesis. Clinical Practice Guidelines in OncologyDavid S Ettinger, Debra K Armstrong, Sally Barbour, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 12, 2012
AntiemesisDavid S Ettinger, Debra K Armstrong, Sally Barbour, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 9, 2017
NCCN Guidelines Insights: Antiemesis, Version 2.2017Michael J Berger, David S Ettinger, Jonathan Aston, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of the Advanced Practitioner in Oncology|February 18, 2021
2018-2019 Drug Updates in Solid TumorsSally Barbour
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 6, 2015
Safety and tolerability of eribulin mesylate in patients with pretreated metastatic breast cancerSusan Goodin, Sally Barbour, James Song, et al.
Journal of the Advanced Practitioner in Oncology|January 25, 2021
Evaluation of the Role and Impact of Ambulatory Clinical Pharmacists in an Academic Comprehensive Cancer CenterLaura A Meleis, Mallika P Patel, Michael DeCoske, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2007
A phase II trial of carboplatin/vinorelbine with pegfilgrastim support for the treatment of patients with advanced non-small cell lung cancerRichard F Riedel, Carolyn Andrews, Jennifer Garst, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2009
Antiemesis. Clinical Practice Guidelines in OncologyDavid S Ettinger, Debra K Armstrong, Sally Barbour, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 12, 2012
AntiemesisDavid S Ettinger, Debra K Armstrong, Sally Barbour, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 9, 2017
NCCN Guidelines Insights: Antiemesis, Version 2.2017Michael J Berger, David S Ettinger, Jonathan Aston, et al.
Pageof 1